But beyond just the survival benefit, the improvement in the patients' quality of life based on their symptoms and their ability to exercise is dramatic.

Conclusions Adjuvant chemotherapy containing paclitaxel can improve the disease-free survival of breast cancer with HER-2 positive, especially for the patients with er and pr negative.

Earlier stage patients benefited with significantly longer survival rates.